Skip to main content
    G

    Grifols SA ADR (GRFS)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - GENERAL • NASDAQ

    $7.54
    +0.30 (+4.14%)

    Market Cap: $4.88B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    38%(14/37)
    Avg Surprise
    -16.92%

    Upcoming Estimates

    Period ending Dec 31, 2026
    EPS Consensus$0.43
    Range$0.35 - $0.51
    2 analysts
    Revenue Consensus
    $2.1B
    Range$2.0B - $2.2B
    11 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.43---
    Sep 26
    Reported Oct 5
    		$N/A$0.27N/ABeat-
    Jun 26
    Reported Jul 28
    		$0.19$0.27-29.63%Miss-13.6%
    Mar 26
    Reported May 7
    		$0.13$0.15-14.97%Miss+35.8%
    Dec 25
    Reported Feb 26
    		$0.29$0.29+0.80%Beat+167.4%
    Sep 25
    Reported Nov 4
    		$0.21$0.24-12.78%Miss+24.0%
    Jun 25
    Reported Jul 28
    		$0.22$0.28-21.43%Miss+46.7%
    Mar 25
    Reported May 12
    		$0.09$0.16-43.86%Miss+32.0%
    Dec 24
    Reported Mar 6
    		$0.11N/A-52.67%Miss-22.8%
    Sep 24
    Reported Nov 7
    		$0.17$0.24-29.17%Miss+54.5%
    Jun 24
    Reported Jul 30
    		$0.15$0.23-34.78%Miss+50.0%
    Mar 24
    Reported May 14
    		$0.07N/A-53.33%Miss+59.8%
    Dec 23
    Reported Mar 5
    		$0.14$0.22-36.36%Miss+118.4%
    Sep 23
    Reported Nov 2
    		$0.11$0.22-50.00%Miss-
    Jun 23
    Reported Jul 27
    		$0.10$0.15-33.33%Miss-24.2%
    Mar 23
    Reported May 15
    		$0.04N/A-72.47%Miss-
    Dec 22
    Reported Feb 27
    		$0.06N/A-57.27%Miss-43.5%
    Sep 22
    Reported Nov 8
    		$0.00$0.00N/ABeat-100.0%
    Jun 22
    Reported Jul 28
    		$0.13N/A-54.84%Miss-52.9%
    Mar 22
    Reported May 5
    		$0.00$0.00N/ABeat-100.0%
    Dec 21
    Reported Feb 28
    		$0.11$0.11+3.09%Beat-60.9%
    Sep 21
    Reported Nov 17
    		$0.31$0.31+0.00%Beat-17.0%
    Jun 21
    Reported Jul 29
    		$0.28$0.27+3.70%Beat-22.2%
    Mar 21
    Reported May 4
    		$0.21$0.22-7.39%Miss-13.8%
    Dec 20
    Reported Feb 26
    		$0.29$0.25+16.00%Beat-6.5%
    Sep 20
    Reported Nov 5
    		$0.37$0.35+5.71%Beat+32.1%
    Jun 20
    Reported Jul 30
    		$0.36$0.37-2.70%Miss+9.1%
    Mar 20
    Reported Apr 21
    		$0.24$0.30-20.00%Miss-4.0%
    Dec 19
    Reported Feb 27
    		$0.31$0.31+0.00%Beat+19.2%
    Sep 19
    Reported Oct 29
    		$0.28$0.30-6.67%Miss-3.4%
    Jun 19
    Reported Jul 31
    		$0.33$0.32+3.13%Beat-2.9%
    Mar 19
    Reported May 7
    		$0.25$0.25+0.00%Beat-16.7%
    Dec 18
    Reported Feb 28
    		$0.26$0.32-18.75%Miss-10.3%
    Sep 18
    Reported Nov 5
    		$0.29$0.31-6.45%Miss+3.6%
    Jun 18
    Reported Jul 27
    		$0.34$0.32+6.25%Beat+21.4%
    Mar 18
    Reported May 3
    		$0.30$0.29+3.45%Beat+11.1%
    Dec 17
    Reported Feb 28
    		$0.29$0.31-6.45%Miss+16.0%
    Sep 17
    Reported Nov 2
    		$0.28$0.30-6.67%Miss-
    Jun 17
    Reported Jul 28
    		$0.28$0.28+0.00%Beat-
    Mar 17
    Reported May 3
    		$0.27$0.26+3.85%Beat-
    Dec 16
    Reported Feb 28
    		$0.25$0.25+0.00%Beat-

    Dividends

    Dividend Metrics

    Forward Yield1.25%
    Forward Annual Dividend$0.09
    Payout Ratio5.04%
    Pay MonthsJul
    GRFS dividend history and ex-dividend datesRun GRFS in the free DRIP calculator

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDA6.44x
    Price/FCF6.11xFCF Yield16.36%
    Profitability
    Profit Margin6.09%Operating Margin15.90%
    ROE6.93%ROIC8.24%
    Financial Health
    Debt/Equity1.35xInterest Coverage2.43x
    Current Ratio2.37xQuick Ratio0.81x
    Trading Statistics
    Beta1.20Avg Volume633.94K
    52-Week High$9.7752-Week Low$6.87

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$7.39
    SMA 20$7.36
    SMA 50$7.62
    SMA 200$8.01
    EMA 10$7.38
    EMA 20$7.41
    EMA 50$7.52
    EMA 200$7.89

    MACD

    Line: -0.06Signal: -0.07Hist: 0.02

    ADX

    ADX: 14.1+DI: 24.3-DI: 27.9

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down92.0
    PSAR$7.15

    Bollinger Bands

    Upper Band$7.57
    Lower Band$7.14
    %B Position585%(Upper)
    Band Width0.93

    RSI (14-Day)

    Neutral
    53.8

    Momentum Oscillators

    Stoch %K40.2
    Stoch %D36.9
    Williams %R-6.0
    ROC (10d)3.3%
    Momentum0.24
    CCI (20d)121.3
    MFI (14d)64.3

    Volatility Measures

    ATR (14d)$0.17(2.3%)
    StdDev (20d)0.11
    Hist Vol26.8%(Moderate)

    Volume Flow

    VWAP$7.50
    OBV13.5M
    AD Line-357.6M
    CMF (20d)-0.315

    Volume Metrics

    Avg Vol (20d)661.5K
    Vol Ratio1.4x
    VWMA (20d)$7.31

    Pivot Points

    R3$7.53
    R2$7.47
    R1$7.35
    Pivot Point$7.29
    S1$7.17
    S2$7.11
    S3$6.99

    Advanced Oscillators

    TSI-9.45
    Ultimate Osc46.0
    KST-32.40

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$1.87B$1.73B$1.96B$1.87B$1.89B$1.79B$1.98B$1.79B$1.82B$1.63B$1.77B$1.60B
    Cost of Revenue$1.17B$1.10B$1.28B$1.11B$1.15B$1.08B$1.21B$1.07B$1.15B$977.30M$1.08B$965.65M
    Gross Profit$704.00M$630.20M$680.40M$751.52M$743.79M$704.64M$766.49M$726.75M$670.44M$648.41M$689.83M$631.83M
    Operating Expenses$375.00M$377.10M$408.17M$368.25M$394.94M$435.78M$394.63M$409.72M$371.12M$444.61M$466.78M$381.24M
    R&D$86.00M$91.48M$135.46M$97.02M$96.19M$96.05M$115.00M$87.88M$90.69M$90.46M$113.58M$87.68M
    SG&A$289.00M$281.00M$155.30M$0$282.76M$325.00M$269.48M$319.43M$299.69M$0$379.55M$300.32M
    Operating Income$329.00M$253.09M$272.23M$383.27M$348.86M$268.86M$371.86M$317.03M$299.32M$203.80M$223.05M$250.59M
    Interest Income$0$0$0$0$9.55M$0$0$0$14.05M$0$0$0
    Interest Expense$80.31M$141.29M$158.49M$156.07M$141.43M$153.59M$15.87M$197.61M$202.51M$169.97M$91.01M$150.94M
    Income Before Tax$247.00M$113.84M$110.05M$198.13M$190.51M$115.27M$210.54M$119.42M$66.98M$47.06M$76.69M$99.59M
    Income Tax Expense$64.00M$24.39M$-14,538,377$54.71M$52.13M$22.84M$126.76M$37.44M$42.21M$24.78M$27.65M$5.58M
    Net Income$154.00M$74.20M$97.33M$126.97M$117.06M$59.73M$68.97M$51.69M$14.84M$21.42M$55.99M$59.54M
    EBITDA$535.00M$360.84M$396.91M$457.05M$438.94M$404.97M$336.54M$468.09M$380.61M$347.53M$334.62M$358.60M
    EBIT$428.00M$255.13M$268.54M$354.20M$331.94M$293.22M$226.41M$359.72M$269.49M$241.91M$226.09M$250.52M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about GRFS

    Government Contracts

    Gov Obligations (TTM)
    $1.27M
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    4.5%
    Active Awards
    22
    New Awards (TTM)
    7
    Avg Remaining Term
    2.4 mo

    Top agency: Department of Veterans Affairs at 73.4% of trailing twelve month obligations across 2 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    36C26026F0037Department of Veterans AffairsDepartment of Veterans Affairs$364000Oct 1, 2025
    36C25526N0141Department of Veterans AffairsDepartment of Veterans Affairs$187878Feb 13, 2026
    36C25626N0079Department of Veterans AffairsDepartment of Veterans Affairs$183367Oct 1, 2025
    36C26026F0015Department of Veterans AffairsDepartment of Veterans Affairs$120000Oct 1, 2025
    36C26026F0019Department of Veterans AffairsDepartment of Veterans Affairs$111000Oct 1, 2025
    36C26026N0067Department of Veterans AffairsDepartment of Veterans Affairs$94176Nov 1, 2025
    36C26326N0209Department of Veterans AffairsDepartment of Veterans Affairs$94081Oct 1, 2025

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    GRFS Valuation and Fair Value

    Forward P/E
    5.8x
    EV/EBITDA
    6.4x
    P/FCF
    6.1x
    PEG
    0.2x
    P/B
    0.8x
    See GNG's fair value

    GRFS Profitability: Margins, ROIC and FCF

    Gross margin
    37.2%
    Operating margin
    15.9%
    Net margin
    6.1%
    ROIC
    8.2%
    ROE
    6.9%
    FCF margin
    8.3%
    FCF yield
    16.4%

    GRFS Competitors

    CompanyTicker
    Cogent Biosciences IncCOGT
    Crispr Therapeutics AGCRSP
    Terns Pharmaceuticals IncTERN
    Scholar Rock Holding CorpSRRK
    Travere Therapeutics IncTVTX
    Concentra Group Holdings Parent, Inc.CON
    PTC Therapeutics IncPTCT
    Lifestance Health Group IncLFST

    Sector: Healthcare

    GRFS Bull Case vs Bear Case

    Bear case

    • GRFS beat EPS estimates in 12.5% of its last 8 reported quarters.
    • GRFS's quarterly revenue changed -0.9% year over year.

    GRFS Earnings: Beat Rate and Next Report

    Beat rate
    1 of 8 quarters (12.5%)
    Average surprise
    -25.5%
    EPS estimate (fiscal period ending Dec 31, 2026)
    $0.43

    GRFS Dividend

    Forward yield
    1.3%
    Payout ratio
    5.0%
    Pay months
    Jul
    GRFS dividend history

    Frequently Asked Questions About GRFS

    What is GRFS's current dividend yield?

    Grifols SA ADR (GRFS) has a forward dividend yield of 1.25%.

    Does GRFS pay dividends?

    Yes, Grifols SA ADR pays dividends with a forward dividend yield of 1.25%.

    What is GRFS's market cap?

    Grifols SA ADR (GRFS) has a market capitalization of $4.88B with a current stock price of $7.54.

    Related stocks

    Sector: Healthcare

    All stocks starting with G

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In